Concepedia

Charles G. Garlisi

CG

47

Publications

2.4K

Citations

27

H-Index

1993

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

ENT and Allergy

WuXi AppTec (China)

Albany Molecular Research (United States)

Charles G. Garlisi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryImmunologyMedicinal ChemistryInflammationNatural SciencesBiochemistryAsthmaAllergy

Publications per year

1993–2022

47

Publications

47

Selective small-molecule inhibition of an RNA structural element

John A. Howe, Hao Wang, Thierry Fischmann et al. · Nature · 2015 · 411 citations

Natural Sciences, Rna Structure Prediction, Selective Small-molecule Inhibition +3

The Kaposi's Sarcoma–related Herpesvirus (KSHV)-encoded Chemokine vMIP-I is a Specific Agonist for the CC Chemokine Receptor (CCR)8

M. Endres, Charles G. Garlisi, Hong Xiao et al. · The Journal of Experimental Medicine · 1999 · 145 citations · Full text

Th2 T Cells, Specific Agonist, Cc Chemokine Receptor +19

High-throughput screening of antibiotic-resistant bacteria in picodroplets

Xinchang Liu, Ronald E. Painter, K. Enesa et al. · Lab on a Chip · 2016 · 118 citations

Catalytic Activity of Human ADAM33

Jun Zou, Feng Zhu, Jianjun Liu et al. · Journal of Biological Chemistry · 2004 · 117 citations · Full text

TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci

Sang Ho Lee, Hao Wang, Marc Labroli et al. · Science Translational Medicine · 2016 · 108 citations

Rows per page

1–5 of 47